Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
Clinical trial NCT06762314 · RECRUITING
Trial details
- NCT number
- NCT06762314
- Sponsor
- Mostafa Bahaa
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-20
- Primary completion
- 2027-09-20
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.